Bioteque (4107) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Bioteque (4107) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$118.17 Million ≈ $3.72 Million USD) by net assets (NT$3.44 Billion ≈ $108.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bioteque - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Bioteque's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4107 liabilities breakdown for a breakdown of total debt and financial obligations.

Bioteque Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioteque ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tiansheng Pharmaceutical Group Co Ltd SHE:002872	-0.011x
Aldel Financial II Inc. Class A Ordinary Shares NASDAQ:ALDF	0.010x
Humana AB (publ) ST:HUM	0.096x
Te Chang Construction Co Ltd TWO:5511	0.048x
SiS Distribution (Thailand) Public Company Limited BK:SIS	0.126x
Chicago Atlantic Real Estate Finance Inc NASDAQ:REFI	0.026x
So-Young International Inc NASDAQ:SY	N/A
Everspin Technologies Inc NASDAQ:MRAM	0.013x

Annual Cash Flow Conversion Efficiency for Bioteque (2006–2024)

The table below shows the annual cash flow conversion efficiency of Bioteque from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Bioteque stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$3.44 Billion ≈ $108.41 Million	NT$702.62 Million ≈ $22.14 Million	0.204x	-2.69%
2023-12-31	NT$3.19 Billion ≈ $100.51 Million	NT$669.40 Million ≈ $21.09 Million	0.210x	-1.30%
2022-12-31	NT$3.03 Billion ≈ $95.52 Million	NT$644.58 Million ≈ $20.31 Million	0.213x	+27.00%
2021-12-31	NT$2.80 Billion ≈ $88.32 Million	NT$469.25 Million ≈ $14.78 Million	0.167x	-29.71%
2020-12-31	NT$2.66 Billion ≈ $83.94 Million	NT$634.51 Million ≈ $19.99 Million	0.238x	-4.95%
2019-12-31	NT$2.49 Billion ≈ $78.39 Million	NT$623.41 Million ≈ $19.64 Million	0.251x	+25.93%
2018-12-31	NT$2.31 Billion ≈ $72.90 Million	NT$460.41 Million ≈ $14.51 Million	0.199x	+26.34%
2017-12-31	NT$2.14 Billion ≈ $67.32 Million	NT$336.51 Million ≈ $10.60 Million	0.157x	-14.05%
2016-12-31	NT$2.08 Billion ≈ $65.45 Million	NT$380.63 Million ≈ $11.99 Million	0.183x	-9.79%
2015-12-31	NT$1.90 Billion ≈ $59.79 Million	NT$385.43 Million ≈ $12.14 Million	0.203x	+3.65%
2014-12-31	NT$1.88 Billion ≈ $59.28 Million	NT$368.71 Million ≈ $11.62 Million	0.196x	+17.08%
2013-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$270.44 Million ≈ $8.52 Million	0.167x	+17.11%
2012-12-31	NT$1.28 Billion ≈ $40.44 Million	NT$183.44 Million ≈ $5.78 Million	0.143x	+19.48%
2011-12-31	NT$1.24 Billion ≈ $39.10 Million	NT$148.43 Million ≈ $4.68 Million	0.120x	-19.79%
2010-12-31	NT$1.24 Billion ≈ $39.17 Million	NT$185.39 Million ≈ $5.84 Million	0.149x	+7.17%
2009-12-31	NT$1.25 Billion ≈ $39.47 Million	NT$174.32 Million ≈ $5.49 Million	0.139x	-40.46%
2008-12-31	NT$1.19 Billion ≈ $37.37 Million	NT$277.23 Million ≈ $8.73 Million	0.234x	+71.56%
2007-12-31	NT$1.17 Billion ≈ $36.95 Million	NT$159.77 Million ≈ $5.03 Million	0.136x	+36.92%
2006-12-31	NT$778.61 Million ≈ $24.53 Million	NT$77.47 Million ≈ $2.44 Million	0.099x	--

About Bioteque

TWO:4107 Taiwan Medical Instruments & Supplies

Market Cap

$252.17 Million

NT$8.00 Billion TWD

Market Cap Rank

#15661 Global

#702 in Taiwan

Share Price

NT$115.50

Change (1 day)

-0.43%

52-Week Range

NT$110.00 - NT$129.00

All Time High

NT$144.00